These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12192066)

  • 1. The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.
    Casbarra A; Piaz FD; Ingallinella P; Orrù S; Pucci P; Pessi A; Bianchi E
    Protein Sci; 2002 Sep; 11(9):2102-12. PubMed ID: 12192066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors.
    Bianchi E; Orrù S; Dal Piaz F; Ingenito R; Casbarra A; Biasiol G; Koch U; Pucci P; Pessi A
    Biochemistry; 1999 Oct; 38(42):13844-52. PubMed ID: 10529230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
    Ingallinella P; Fattori D; Altamura S; Steinkühler C; Koch U; Cicero D; Bazzo R; Cortese R; Bianchi E; Pessi A
    Biochemistry; 2002 Apr; 41(17):5483-92. PubMed ID: 11969409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the P'-region of peptide inhibitors of hepatitis C virus NS3/4A protease.
    Ingallinella P; Bianchi E; Ingenito R; Koch U; Steinkühler C; Altamura S; Pessi A
    Biochemistry; 2000 Oct; 39(42):12898-906. PubMed ID: 11041854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.
    Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R
    J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel azapeptide inhibitors of hepatitis C virus serine protease.
    Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
    J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis.
    Xue W; Wang M; Jin X; Liu H; Yao X
    Mol Biosyst; 2012 Oct; 8(10):2753-65. PubMed ID: 22833015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
    Barbato G; Cicero DO; Cordier F; Narjes F; Gerlach B; Sambucini S; Grzesiek S; Matassa VG; De Francesco R; Bazzo R
    EMBO J; 2000 Mar; 19(6):1195-206. PubMed ID: 10716920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
    Tautz N; Kaiser A; Thiel HJ
    Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization.
    Perni RB; Pitlik J; Britt SD; Court JJ; Courtney LF; Deininger DD; Farmer LJ; Gates CA; Harbeson SL; Levin RB; Lin C; Lin K; Moon YC; Luong YP; O'Malley ET; Rao BG; Thomson JA; Tung RD; Van Drie JH; Wei Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1441-6. PubMed ID: 15006379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
    de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G
    J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease.
    Zhu H; Briggs JM
    Proteins; 2011 Aug; 79(8):2428-43. PubMed ID: 21633972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS
    Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
    J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpin mechanism of hepatitis C virus nonstructural 3 (NS3) protease inhibition: induced fit as a mechanism for narrow specificity.
    Richer MJ; Juliano L; Hashimoto C; Jean F
    J Biol Chem; 2004 Mar; 279(11):10222-7. PubMed ID: 14701815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the origin of the slow-binding inhibition of HCV NS3 serine protease by a novel substrate based inhibitor.
    Liu Y; Saldivar A; Bess J; Solomon L; Chen CM; Tripathi R; Barrett L; Richardson PL; Molla A; Kohlbrenner W; Kati W
    Biochemistry; 2003 Jul; 42(29):8862-9. PubMed ID: 12873147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.